PATIENT SURVIVAL AFTER GASTRECTOMY FOR GASTRIC CANCER: A RETROSPECTIVE CLINICAL STUDY

Authors

  • Sariboyeva Husniya Tohirjon qizi

    Tashkent State Medical University

    Author

  • Haytbayeva Muhayo Ravshanovna

    Academic Supervisor Tashkent State Medical University

    Author

Keywords:
Gastric cancer, gastrectomy, survival, adjuvant therapy, retrospective study.
Abstract

This paper presents the results of a retrospective clinical study of 40 patients who underwent gastrectomy (subtotal or total) for gastric cancer. Case histories were obtained from the Republican Specialized Scientific-Practical Medical Center of Oncology and Radiology of the Republic of Uzbekistan; data were collected over a five-year follow-up period. Survival was assessed depending on the type of operation, sex, disease stage, presence of postoperative complications, and use of adjuvant therapy. It was found that subtotal gastrectomy was associated with higher survival (93%) compared with total gastrectomy (40%), and adjuvant therapy increased survival to 70%.

References

1. Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–249. https://doi.org/10.3322/caac.21660

2. Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2021 (6th edition). Gastric Cancer. 2023;26(1):1–25. https://doi.org/10.1007/s10120-022-01331-8

3. Smyth EC, Nilsson M, Grabsch HI, et al. Gastric cancer. Lancet. 2020;396(10251):635–648. https://doi.org/10.1016/S0140-6736(20)31288-5

4. Bozzetti F, Marubini E, Bonfanti G, et al. Subtotal versus total gastrectomy for gastric cancer: five-year survival rates in a multicenter randomized Italian trial. Ann Surg. 1999;230(2):170–178. https://doi.org/10.1097/00000658-199908000-00006

5. Bang YJ, Kim YW, Yang HK, et al. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC). Lancet. 2012;379(9813):315–321. https://doi.org/10.1016/S0140-6736(11)61873-4

6. Al-Batran SE, Homann N, Pauligk C, et al. Perioperative chemotherapy with FLOT versus ECF/ECX (FLOT4). Lancet. 2019;393(10184):1948–1957. https://doi.org/10.1016/S0140-6736(18)32557-1

7. Chandanos E, Lagergren J. Oestrogen and the enigmatic male predominance of gastric cancer. Eur J Cancer. 2008;44(16):2397–2403. https://doi.org/10.1016/j.ejca.2008.07.031

8. Plummer M, Franceschi S, Vignat J, et al. Global burden of gastric cancer attributable to Helicobacter pylori. Int J Cancer. 2015;136(2):487–490. https://doi.org/10.1002/ijc.28999.

Downloads
Published
2026-05-18
Issue
Vol. 2 No. 5 (2026)
Section
Articles
License
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite

PATIENT SURVIVAL AFTER GASTRECTOMY FOR GASTRIC CANCER: A RETROSPECTIVE CLINICAL STUDY. (2026). Eureka Journal of Health Sciences & Medical Innovation, 2(5), 210-215. https://eurekaoa.com/index.php/5/article/view/1028